Impact of Therapeutic Strategies in the Pediatric Inflammatory Bowel Disease: a Population Based Study (1988-2011).

NCT02392221 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 966

Last updated 2026-04-27

No results posted yet for this study

Summary

Crohn's disease (CD) and ulcerative colitis (UC) are chronic Inflammatory Bowel Disease (IBD) and may affect all segments of the digestive tract.

Conditions

  • Pediatric Inflammatory Bowel Disease

Sponsors & Collaborators

  • Funding from DGOS (PHRC IR 2013 and PRME)

    collaborator UNKNOWN
  • Centre Hospitalier Universitaire, Amiens

    lead OTHER

Principal Investigators

  • Mathurin Fumery, Doctor · CHU Amiens France

  • Jean-Louis Dupas, professor · CHU Amiens France

Eligibility

Max Age
26 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2019-04-30
Completion
2019-04-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02392221 on ClinicalTrials.gov